Friday, July 11, 2014 5:22:53 PM
http://208.71.46.190/search/srpcache?ei=UTF-8&p=http%3A%2F%2Fwww.1stprestige.com%2F&fr=yfp-t-901&u=http://cc.bingj.com/cache.aspx?q=http%3a%2f%2fwww.1stprestige.com%2f&d=4692510799824017&mkt=en-US&setlang=en-US&w=QU2__HJex_hV6ArL3-8Gm-jfr62YNmdh&icp=1&.intl=us&sig=uZ2FNV.bQFkwO7qOv09Clg--
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM